Display options
Cite
Mercx S, Smargiasso N, Chaumont F, et al. Inactivation of the β(1,2)-xylosyltransferase and the α(1,3)-fucosyltransferase genes in . Front Plant Sci. 2017;8:403doi: 10.3389/fpls.2017.00403.
Mercx, S., Smargiasso, N., Chaumont, F., De Pauw, E., Boutry, M., & Navarre, C. (2017). Inactivation of the β(1,2)-xylosyltransferase and the α(1,3)-fucosyltransferase genes in . Frontiers in plant science, 8403. https://doi.org/10.3389/fpls.2017.00403
Mercx, Sébastien, et al. "Inactivation of the β(1,2)-xylosyltransferase and the α(1,3)-fucosyltransferase genes in ." Frontiers in plant science vol. 8 (2017): 403. doi: https://doi.org/10.3389/fpls.2017.00403
Mercx S, Smargiasso N, Chaumont F, De Pauw E, Boutry M, Navarre C. Inactivation of the β(1,2)-xylosyltransferase and the α(1,3)-fucosyltransferase genes in . Front Plant Sci. 2017 Mar 27;8:403. doi: 10.3389/fpls.2017.00403. eCollection 2017. PMID: 28396675; PMCID: PMC5366340.
Copy Download .nbib Format: NLM
Share it on

Front Plant Sci. 2017 Mar 27;8:403. doi: 10.3389/fpls.2017.00403. eCollection 2017.

Inactivation of the β(1,2)-xylosyltransferase and the α(1,3)-fucosyltransferase genes in .

Frontiers in plant science

Sébastien Mercx, Nicolas Smargiasso, François Chaumont, Edwin De Pauw, Marc Boutry, Catherine Navarre

Affiliations

  1. Institut des Sciences de la Vie, Université catholique de Louvain Louvain-la-Neuve, Belgium.
  2. Mass Spectrometry Laboratory, Molecular Systems Research Unit, Université de Liège Liège, Belgium.

PMID: 28396675 PMCID: PMC5366340 DOI: 10.3389/fpls.2017.00403

Abstract

Plants or plant cells can be used to produce pharmacological glycoproteins such as antibodies or vaccines. However these proteins carry

Keywords: antibody; gene editing; glyco-engineering; glycoproteins; humanized N-glycosylation; molecular farming; plant-specific glycans; suspension cells

References

  1. J Biol Chem. 2000 Apr 14;275(15):11451-8 - PubMed
  2. Plant Biotechnol J. 2008 Sep;6(7):702-21 - PubMed
  3. Front Plant Sci. 2016 Feb 01;7:40 - PubMed
  4. FEBS Lett. 2004 Mar 12;561(1-3):132-6 - PubMed
  5. Int Arch Allergy Immunol. 2007;142(2):99-115 - PubMed
  6. Plant Biotechnol J. 2008 May;6(4):392-402 - PubMed
  7. Appl Microbiol Biotechnol. 2016 Apr;100(8):3451-61 - PubMed
  8. Front Plant Sci. 2016 Feb 24;7:200 - PubMed
  9. Plant Biol (Stuttg). 2005 May;7(3):292-9 - PubMed
  10. Plant Biotechnol J. 2016 Feb;14 (2):533-42 - PubMed
  11. Nat Biotechnol. 2006 Dec;24(12):1591-7 - PubMed
  12. Curr Pharm Des. 2013;19(31):5503-12 - PubMed
  13. J Biol Chem. 2009 Jul 31;284(31):20479-85 - PubMed
  14. Mol Genet Metab. 2014 May;112(1):1-8 - PubMed
  15. Nat Biotechnol. 2013 Aug;31(8):688-91 - PubMed
  16. Protein Cell. 2011 Jan;2(1):41-7 - PubMed
  17. Int J Mol Sci. 2015 Dec 02;16(12):28549-65 - PubMed
  18. Plant Biotechnol J. 2013 Sep;11(7):867-74 - PubMed
  19. Annu Rev Plant Biol. 2013;64:327-50 - PubMed
  20. Biosci Biotechnol Biochem. 2001 Nov;65(11):2482-8 - PubMed
  21. Biotechnology (N Y). 1990 Mar;8(3):217-21 - PubMed
  22. Plant Biotechnol J. 2017 Feb;15(2):197-206 - PubMed
  23. Curr Opin Plant Biol. 2016 Nov 30;36:1-8 - PubMed
  24. Front Plant Sci. 2016 Mar 11;7:297 - PubMed
  25. Plant Mol Biol. 2000 Jul;43(4):495-502 - PubMed
  26. Vaccine. 2014 Oct 21;32(46):6098-106 - PubMed
  27. Plant Biotechnol J. 2017 Feb 3;:null - PubMed
  28. Transgenic Res. 2017 Mar 22;:null - PubMed
  29. Plant Biotechnol J. 2014 May;12(4):457-67 - PubMed
  30. Genome Biol. 2015 Dec 15;16:280 - PubMed
  31. Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3570-5 - PubMed
  32. Glycobiology. 1998 Jul;8(7):651-61 - PubMed
  33. Plant Biotechnol J. 2011 Dec;9(9):1109-19 - PubMed
  34. BioDrugs. 2014 Apr;28(2):145-59 - PubMed

Publication Types